Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

482 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cross-reactivity between Anisakis spp. and wasp venom allergens.
Rodríguez-Pérez R, Monsalve RI, Galán A, Perez-Piñar T, Umpierrez A, Lluch-Bernal M, Polo F, Caballero ML. Rodríguez-Pérez R, et al. Among authors: galan a. Int Arch Allergy Immunol. 2014;163(3):179-84. doi: 10.1159/000358060. Epub 2014 Feb 13. Int Arch Allergy Immunol. 2014. PMID: 24525615
Anaphylaxis to Vespa velutina nigrithorax: Pattern of Sensitization for an Emerging Problem in Western Countries.
Vidal C, Armisén M, Monsalve R, González-Vidal T, Lojo S, López-Freire S, Méndez P, Rodríguez V, Romero L, Galán A, González-Quintela A. Vidal C, et al. Among authors: galan a. J Investig Allergol Clin Immunol. 2021 Jun 22;31(3):228-235. doi: 10.18176/jiaci.0474. Epub 2020 Feb 11. J Investig Allergol Clin Immunol. 2021. PMID: 32043465 Free article.
Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1/2 (FANCOLEN-1) and long-term clinical trials.
Río P, Zubicaray J, Navarro S, Gálvez E, Sánchez-Domínguez R, Nicoletti E, Sebastián E, Rothe M, Pujol R, Bogliolo M, John-Neek P, Bastone AL, Schambach A, Wang W, Schmidt M, Larcher L, Segovia JC, Yáñez RM, Alberquilla O, Díez B, Fernández-García M, García-García L, Ramírez M, Galy A, Lefrere F, Cavazzana M, Leblanc T, García de Andoin N, López-Almaraz R, Catalá A, Barquinero J, Rodríguez-Perales S, Rao G, Surrallés J, Soulier J, Díaz-de-Heredia C, Schwartz JD, Sevilla J, Bueren JA; FANCOLEN-1 gene therapy investigators. Río P, et al. Lancet. 2025 Dec 21;404(10471):2584-2592. doi: 10.1016/S0140-6736(24)01880-4. Epub 2024 Dec 3. Lancet. 2025. PMID: 39642902 Clinical Trial.
Education and Training in Peritoneal Surface Oncology.
González-Moreno S, Deraco M, Kusamura S, Bijelic L, Lambert LA, Dromain C, Bibeau F, Liauw W, Reis A, Galan A, Sugarbaker PH. González-Moreno S, et al. Among authors: galan a. J Surg Oncol. 2024 Sep 24. doi: 10.1002/jso.27833. Online ahead of print. J Surg Oncol. 2024. PMID: 39318155 Review.
First-in-Class Mitogen-Activated Protein Kinase p38α: MAPK-Activated Protein Kinase-2 (MK2) Dual Signal Modulator with Anti-inflammatory and Endothelial-stabilizing Properties.
Tulapurkar ME, Shirey KA, Lugkey KN, Luo W, Lal R, Galan A, Mahmoud O, McClean N, Thangaraju K, Cericola D, Lewis D, Murphy WA, Fletcher S, MacKerell AD Jr, Vogel SN, Shapiro P, Hasday JD. Tulapurkar ME, et al. Among authors: galan a. J Pharmacol Exp Ther. 2024 Sep 16:JPET-AR-2024-002281. doi: 10.1124/jpet.124.002281. Online ahead of print. J Pharmacol Exp Ther. 2024. PMID: 39284624 Free article.
Atrophic Macular Degeneration and Stem Cell Therapy: A Clinical Review.
Babighian S, Zanella MS, Gattazzo I, Galan A, Gagliano C, D'Esposito F, Zeppieri M. Babighian S, et al. Among authors: galan a. Adv Exp Med Biol. 2024 Sep 12. doi: 10.1007/5584_2024_819. Online ahead of print. Adv Exp Med Biol. 2024. PMID: 39259423
482 results